ChitogenX Inc.
CHNXF
$0.0071
-$0.0039-35.46%
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.81% | 612.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 75.52% | 4,362.16% | |||
| Operating Income | -75.52% | -4,362.16% | |||
| Income Before Tax | -82.48% | -110.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -82.48% | -110.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -82.48% | -110.20% | |||
| EBIT | -75.52% | -4,362.16% | |||
| EBITDA | -78.77% | -1,567.96% | |||
| EPS Basic | -82.76% | -107.14% | |||
| Normalized Basic EPS | -83.33% | -100.00% | |||
| EPS Diluted | -82.76% | -107.14% | |||
| Normalized Diluted EPS | -83.33% | -100.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
